A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)

Phase 2 Completed 66 enrolled Sparrow Pharmaceuticals

Non-randomizedSequentialSingle-blindTreatment

This will be a single-blind, placebo-controlled phase 2 trial to compare prednisolone effects with and without SPI-62 in participants with PMR.

Evaluation	Drug	Modality	Dose	Route
Subject	Prednisolone	Other / unclassified	—	Oral
Subject	clofutriben	Small molecule	—	Oral
Subject	Prednisolone	Other / unclassified	10 mg	Oral